Literature DB >> 16417595

Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.

K Frei1, D D Truong, D Dressler.   

Abstract

Hemifacial spasm (HFS) is characterized by involuntary irregular clonic or tonic movements of the muscles innervated by cranial nerve VII on one side of the face, and is most often a result of vascular compression of the facial nerve at the root exit zone (Muscle and Nerve 1998;21:1740). Disability associated with this disorder ranges from social embarrassment to interference with vision resulting from involuntary eye closure. Treatment of HFS most often involves botulinum toxin injections, but may also include medications and surgery. We describe treatment with the three types of botulinum toxin currently commercially available--Botox, Dysport and Myobloc/NeuroBloc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417595     DOI: 10.1111/j.1468-1331.2006.01442.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

1.  Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study.

Authors:  C Butera; R Guerriero; S Amadio; D Ungaro; H Tesfaghebriel; F Bianchi; G Comi; U Del Carro
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

Review 2.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

3.  Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.

Authors:  Monika Rudzińska; Magdalena Wójcik; Andrzej Szczudlik
Journal:  J Neural Transm (Vienna)       Date:  2010-05-14       Impact factor: 3.575

Review 4.  Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment.

Authors:  Bettina Wabbels; Peter Roggenkämper
Journal:  J Neural Transm (Vienna)       Date:  2012-01-10       Impact factor: 3.575

5.  Spasm Freedom Following Microvascular Decompression for Hemifacial Spasm: Systematic Review and Meta-Analysis.

Authors:  Katherine Holste; Ronald Sahyouni; Zoe Teton; Alvin Y Chan; Dario J Englot; John D Rolston
Journal:  World Neurosurg       Date:  2020-04-16       Impact factor: 2.104

6.  Botulinum toxin use as an adjunctive modality in a patient with multiple flexor tendon ruptures.

Authors:  Wade D Kubat; Mark Rekant
Journal:  Hand (N Y)       Date:  2008-03-14

7.  Botulinum toxin A improves psychological distress in patients with hemifacial spasm.

Authors:  Chengyun Wang; Xiangyu Zhu; Lei Xia; Peng Xie; Xiangyang Tian; Jin Shang; Qiu Han
Journal:  Acta Neurol Belg       Date:  2021-01-29       Impact factor: 2.396

Review 8.  Botulinum toxin: bioweapon & magic drug.

Authors:  Ram Kumar Dhaked; Manglesh Kumar Singh; Padma Singh; Pallavi Gupta
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

9.  Botulinum toxin in hemifacial spasm: Revisited.

Authors:  Sukhbir Singh
Journal:  Indian J Plast Surg       Date:  2013-01

10.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.